We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

SurModics Inc (SRDX) Common Stock USD0.05

Sell:$41.78 Buy:$41.79 Change: $0.1 (0.24%)
Market closed |  Prices as at close on 22 July 2024 | Switch to live prices |
Change: $0.1 (0.24%)
Market closed |  Prices as at close on 22 July 2024 | Switch to live prices |
Change: $0.1 (0.24%)
Market closed |  Prices as at close on 22 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.

Contact details

9924 W 74th St
United States
+1 (952) 5007000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$595.99 million
Shares in issue:
14.26 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Gary Maharaj
    President, Chief Executive Officer, Director
  • Timothy Arens
    Chief Financial Officer, Senior Vice President - Finance and Information Technology
  • Gordon Weber
    Senior Vice President - Legal, General Counsel, Secretary
  • Joseph Stich
    Senior Vice President of Human Resources, President - In Vitro Diagnostics
  • Charles Olson
    Senior Vice President, President - Medical Device Coatings
  • Teri Sides
    Senior Vice President, President - Vascular Interventions

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.